Increase of β-endorphin secretion by syringin, an active principle of Eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats

Hormone and Metabolic Research

Volumn 39, Issue 12, 2007, Pages 894-898

  Niu, H S ^a   Hsu, F L ^a   Liu, I M ^b   Cheng, J T ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

endorphin; opioid receptors; Streptozotocin induced diabetic rats; Syringin

Indexed keywords

BETA ENDORPHIN; GLUCOSE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; SYRINGIN;

ADRENAL MEDULLA; ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELEUTHEROCOCCUS SENTICOSUS; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

ADRENAL MEDULLA; ADRENALECTOMY; ANIMALS; BETA-ENDORPHIN; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ELEUTHEROCOCCUS; GLUCOSIDES; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, KNOCKOUT; PHENYLPROPIONATES; PHYTOTHERAPY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; STREPTOZOCIN; TISSUE EXTRACTS;

ANIMALIA; ARALIACEAE; ELEUTHEROCOCCUS SENTICOSUS; MUS; RATTUS;

EID: 38149006376     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993154     Document Type: Article

References (24)

1. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004; 21: 657-665
2. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003; 26: 3230-3236
3. Davydov M, Krikorian AD. Eleutherococcus senticosus (Rupr. & Maxim. Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol 2000; 72: 345-393
4. Kwan CY, Zhang WB, Sim SM, Deyama T, Nishibe S. Vascular effects of Siberian ginseng (Eleutherococcus senticosus): endothelium-dependent NO- and EDHF-mediated relaxation depending on vessel size. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 473-480
5. Asano K, Takahashi T, Miyashita M, Matsuzaka A, Muramatsu S, Kuboyama M, Kugo H, Imai J. Effect of Eleutheroccocus senticosus extract on human physical working capacity. Planta Med 1986; 3: 175-177
6. Goulet ED, Dionne IJ. Assessment of the effects of Eleutherococcus senticosus on endurance performance. Int J Sport Nutr Exerc Metab 2005; 15: 75-83
7. Hikino H, Takahashi M, Otake K, Konn C. Isolation and hypoglycemic activity of eleutherans A, B, C, D, E, F, and G: glycans of Eleutherococcus senticosus roots. J Nat Prod 1986; 49: 293-297
8. Cho JY, Nam KH, Kim AR, Park J, Yoo ES, Baik KU, Yu YH, Park MH. In-vitro and in-vivo immunomodulatory effects of syringin. J Pharm Pharmacol 2001; 53: 1287-1294
9. Ruijun Z, Jinkang Q, Gnanghua Y, Baozhen W, Xiulan W. Medicinal protection with Chinese herb-compound against radiation damage. Aviat Space Environ Med 1990; 61: 729-731
10. Choi J, Shin KM, Park HJ, Jung HJ, Kim HJ, Lee YS, Rew JH, Lee KT. Anti-inflammatory and antinociceptive effects of sinapyl alcohol and its glucoside syringin. Planta Med 2004; 70: 1027-1032
11. Curry DL, Li CH. Stimulation of insulin secretion by beta-endorphin (1-27 and 1-31). Life Sci 1987; 40: 2053-2058
12. Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TY. Plasma glucose lowering effect of β-endorphin in streptozotocin-induced diabetic rats. Horm Metab Res 2002; 34: 570-576
13. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. μ-Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 1998; 54: 321-326
14. Liu IM, Chi TC, Shiao GC, Lin MT, Cheng JT. Loss of plasma glucose lowering response to cold stress in opioid μ-receptor knock-out diabetic mice. Neurosci Lett 2001; 307: 81-84
15. Niu HS, Hsu FL, Liu IM, Cheng JT. Syringin as the active principle of Eleutherococcus senticosus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med (submitted)
16. Hwang SL, Liu IM, Tzeng TF, Cheng JT. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia 2005; 48: 767-775
17. Wohaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes 1987; 36: 1014-1018
18. Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β-endorphin and adrenal corticotropin are secreted concomitantly by the pituitary gland. Science 1977; 197: 1367-1369
19. Hanbauer I, Kelly GD, Saiani L, Yang HY. [Met5]-enkephalin-like peptides of the adrenal medulla: release by nerve stimulation and functional implications. Peptides 1982; 3: 469-473
20. Arefolov VA, Dmitriev AD, Tennov AV, Val'dman AV. Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry. Biull Eksp Biol Med 1986; 101: 445-447
21. Hsu CT, Liu IM, Cheng JT. Increase of beta-endorphin biosynthesis in the adrenal gland of streptozotocin-induced diabetic rats. Neurosci Lett 2002; 318: 57-60
22. Liu IM, Chen WC, Cheng JT. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 2003; 307: 1196-1204
23. Gourlay GK. Advances in opioid pharmacology. Support Care Cancer 2005; 13: 153-159
24. Cheng JT, Liu IM, Chi TC, Tzeng TF. Increase of opioid μ-receptor gene expression in streptozotocin-induced diabetic rats. Horm Metab Res 2001; 33: 467-471